Your browser doesn't support javascript.
loading
rAAV-based and intraprostatically delivered miR-34a therapeutics for efficient inhibition of prostate cancer progression.
Ai, Jianzhong; Li, Jia; Su, Qin; Ma, Hong; He, Ran; Wei, Qiang; Li, Hong; Gao, Guangping.
Affiliation
  • Ai J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. jianzhong.ai@wchscu.cn.
  • Li J; Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, USA. jianzhong.ai@wchscu.cn.
  • Su Q; Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, USA.
  • Ma H; Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, USA.
  • He R; Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, USA.
  • Wei Q; Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, USA.
  • Li H; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
  • Gao G; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Gene Ther ; 29(7-8): 418-424, 2022 08.
Article in En | MEDLINE | ID: mdl-34226687
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / MicroRNAs Limits: Animals / Humans / Male Language: En Journal: Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / MicroRNAs Limits: Animals / Humans / Male Language: En Journal: Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2022 Type: Article Affiliation country: China